A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia. (2019)


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pntd.0006988

PubMed Identifier: 30653490

Publication URI: http://europepmc.org/abstract/MED/30653490

Type: Journal Article/Review

Volume: 13

Parent Publication: PLoS neglected tropical diseases

Issue: 1

ISSN: 1935-2727